Cingulate Therapeutics names new chief operating officer.
M2 EQUITYBITES-April 3, 2018-Cingulate Therapeutics names new chief operating officer
(C)2018 M2 COMMUNICATIONS http://www.m2.com
Cingulate Therapeutics LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilising its precision timed release drug delivery platform technology, has named Laurie A. Myers, PhD as its new chief operating officer, it was reported on Monday.
Presently, Myers served as a founding member of the Cingulate Therapeutics board of directors. She has also played key role in clinical drug development, marketing and commercialisation for global pharmaceutical companies, including Novartis, DuPont, Pfizer and Sanofi (including predecessor companies), which included leadership positions in both R&D and marketing. Myers
has been named a brand champion in the PharmaVOICE 100. She has contributed to two investor organisations, Mid Atlantic Bio Angels and Mid Atlantic Diamond Ventures, and was commercial advisor to another start-up, EpiGen Pharma.
Shane J. Schaffer, PharmD, chairman and chief executive officer of Cingulate Therapeutics, said: "I have great confidence in the value that Laurie's extensive industry knowledge, leadership experience and strategic insights bring to Cingulate. Laurie's experience in all aspects of branded pharmaceutical life cycle management from clinical drug development through commercialisation is a major asset, which will also serve useful as she helps direct the company's clinical research, and eventual commercial functions. As we bring the proprietary manufacturing operations online for clinical trials and eventual commercial scale production, having an experienced COO on board is crucial."
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Apr 3, 2018|
|Previous Article:||MediciNova's liver disease drug meets primary endpoint in phase 2 clinical trial.|
|Next Article:||PCOM School of Pharmacy appoints new dean.|